Skip to main content
رجوع
OCS logo

Oculis Holding AG

جودة البيانات: 100%
OCS
NASDAQ Healthcare Biotechnology
KWD 24.52
▼ KWD 0.08 (-0.33%)
القيمة السوقية: 1.40B
نطاق اليوم
KWD 24.03 KWD 24.64
نطاق 52 أسبوعًا
KWD 14.00 KWD 30.68
حجم التداول
197,128
متوسط 50 يوم / 200 يوم
KWD 27.16 / KWD 21.03
الإغلاق السابق
KWD 24.60

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E -14.8 0.3
P/B 7.1 2.9
ROE % -70.1 3.7
Net Margin % 3.8
Rev Growth 5Y % 10.0
D/E 0.0 0.2

السعر المستهدف للمحللين

Hold
KWD 45.670 +86.3%
Low: KWD 36.000 High: KWD 51.000
ربحية السهم المستقبلية
-KWD 1.742
الإيرادات المقدّرة
5.2 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 2.664
-KWD 0.576 – KWD 10.961
640 M 2
FY2029 KWD 0.730
-KWD 0.158 – KWD 3.004
330 M 4
FY2028 -KWD 1.141
-KWD 16.556 – KWD 26.930
120 M 6

النقاط الرئيسية

Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -62.51M
PEG of 0.60 suggests growth is underpriced

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-70.09%
ROIC-29.89%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.01
Current Ratio5.96
Interest Coverage-99.49

التقييم

P/E Ratio
-14.83
P/B Ratio7.14
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -100.00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -94.51M
ROE -70.09% ROA -40.01%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -62.51M
ROIC -29.89% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.01 Current Ratio 5.96
Interest Coverage -99.49 Dividend Yield 0.00%
Valuation
P/E Ratio -14.83 P/B Ratio 7.14
P/S Ratio N/A PEG Ratio 0.60
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 1.40B Enterprise Value 1.32B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 686,000.0 0.0 0.0 0.0
Net Income -94.51M -85.78M -88.80M -38.70M -18.55M
EPS (Diluted) -1.81 -2.12 -2.97 -1.18 -0.57
Gross Profit 0.0 -51.40M 0.0 0.0 0.0
Operating Income -79.15M -73.20M -80.71M -32.38M -13.23M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 236.23M 120.35M 114.35M 37.06M 58.04M
Total Liabilities 39.94M 46.97M 20.63M 135.05M 119.00M
Shareholders' Equity 196.29M 73.38M 93.73M -97.99M -60.96M
Total Debt 2.32M 1.18M 605,000.0 123.08M 114.27M
Cash & Equivalents 81.42M 27.71M 38.33M 19.79M 46.28M
Current Assets 219.14M 104.90M 101.02M 23.66M 47.98M
Current Liabilities 36.79M 44.24M 19.09M 12.02M 4.06M